Susquehanna Advisors Group Inc. Makes New Investment in Semler Scientific, Inc. (NASDAQ:SMLR)

Susquehanna Advisors Group Inc. bought a new position in Semler Scientific, Inc. (NASDAQ:SMLRFree Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 498,675 shares of the company’s stock, valued at approximately $26,928,000. Semler Scientific accounts for 0.8% of Susquehanna Advisors Group Inc.’s holdings, making the stock its 20th largest holding. Susquehanna Advisors Group Inc. owned approximately 5.38% of Semler Scientific as of its most recent SEC filing.

A number of other large investors have also modified their holdings of SMLR. Global Retirement Partners LLC boosted its holdings in Semler Scientific by 62.5% in the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after acquiring an additional 500 shares during the period. NewEdge Advisors LLC lifted its position in shares of Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock worth $40,000 after purchasing an additional 557 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in shares of Semler Scientific by 13.2% in the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company’s stock valued at $261,000 after purchasing an additional 584 shares during the period. Jones Financial Companies Lllp acquired a new stake in Semler Scientific during the 4th quarter valued at $34,000. Finally, Larson Financial Group LLC purchased a new stake in Semler Scientific during the 4th quarter worth $38,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Down 8.2 %

SMLR stock opened at $29.83 on Tuesday. The company has a market capitalization of $286.28 million, a PE ratio of 6.08 and a beta of 1.29. The stock’s 50 day moving average is $38.32 and its two-hundred day moving average is $45.99. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $81.56.

Semler Scientific (NASDAQ:SMLRGet Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $3.21. The firm had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Analyst Ratings Changes

Separately, Lake Street Capital raised their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

View Our Latest Research Report on Semler Scientific

Semler Scientific Profile

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Read More

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.